Ultrasonography, although widely used as a non-invasive diagnostic tool for MASLD, relies on the visual identification of hepatic steatosis and may not capture the full spectrum of liver injury and metabolic dysfunction represented by L-FABP levels [20]. The gene discussed is FABP1; the disease is fatty liver disease.